Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis

2010/10/11 by Ioannis Gallos, Ioannis D. Gallos, Manjeet Shehmar +5 · 25 citations
Immunology and Microbiology · Medicine · #Cochrane Library #Endometrial hyperplasia #Family planning #Gynecological conditions and treatments #Gynecology #Hyperplasia #Internal medicine #Levonorgestrel #Medicine #Meta-analysis #Obstetrics #Population #Reproductive Health and Contraception #Reproductive System and Pregnancy #Research methodology

paper · doi:10.1016/j.ajog.2010.07.037

openalex publication_date 2010/10/11 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Progestin intrauterine device in an adolescent with grade 2 endometrial cancer. [europepmc]
• Longterm management of Polycystic Ovarian Syndrome (PCOS). [europepmc]
• Current Issues in the Diagnosis and Treatment of Endometrial Carcinoma. [europepmc]
• Fertility preservation in women with cervical, endometrial or ovarian cancers. [europepmc]
• Fertility-preserving treatment in women with early endometrial cancer: the Chinese experience. [europepmc]
• Effectiveness of progestin-based therapy for morbidly obese women with complex atypical hyperplasia. [europepmc]
• The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia. [europepmc]
• National patterns of care and fertility outcomes for reproductive-aged women with endometrial cancer or atypical hyperplasia. [europepmc]
• Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy. [europepmc]
• Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study. [europepmc]
• Improving response to progestin treatment of low-grade endometrial cancer. [europepmc]
• Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. [europepmc]
• Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy. [europepmc]
• Survey on Reporting of Endometrial Biopsies From Women on Progestogen Therapy for Endometrial Atypical Hyperplasia/Endometrioid Carcinoma. [europepmc]
• Conservative Surgery in Endometrial Cancer. [europepmc]
• Effectiveness of Megestrol for the Treatment of Patients with Atypical Endometrial Hyperplasia or Endometrial Endometrioid Adenocarcinoma (Stage IA, Well Differentiated). [europepmc]
• Progesterone Actions and Resistance in Gynecological Disorders. [europepmc]
• Could Moesin Be a New Marker for Indicating Progression in Endometrial Cancer? [europepmc]
• A Prospective Cohort Study of Metformin as an Adjuvant Therapy for Infertile Women With Endometrial Complex Hyperplasia/Complex Atypical Hyperplasia and Their Subsequent Assisted Reproductive Technology Outcomes. [europepmc]
• Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review. [europepmc]
• Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis. [europepmc]
• Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis. [europepmc]
• Atypical Endometrial Hyperplasia and Concurrent Cancer: A Comprehensive Overview on a Challenging Clinical Condition. [europepmc]
• Fertility-sparing re-treatment for endometrial cancer and atypical endometrial hyperplasia patients with progestin-resistance: a retrospective analysis of 61 cases. [europepmc]
• A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia. [europepmc]